Dr. Michael D WintherAssociate Director, Office of Strategic Alliances & Knowledge Management, Genome Institute of Singapore (GIS)
Transforming Collaborative Healthcare: Efficient Addressing of Emerging Lifestyle Challenges
"The 6 largest economies in SEA (Singapore, Malaysia, Indonesia, Thailand, Philippines and Vietnam) are facing unprecedented rise in healthcare cost. Industry experts predicted that the rise of healthcare cost will outpace both GDP and population growth, leading to an estimated total healthcare cost of more than USD 750 billion by 2025."
In Singapore, healthcare expenditure is expected to triple by 2030 (to SGD 44 billion) driven by ageing population and increase of NCD prevalence. The Singapore government has allocated SGD 10.2 billion for healthcare expenditure in Budget 2018 aiming to build new healthcare capacity to meet the rising demand and invest in new medical technologies to improve care quality. In the next 5 years, we are expected to see more general and community hospitals, polyclinics, nursing homes and elderly care centres across the island.
International experts believe that Healthcare Innovation is the key to create a more efficient and sustainable healthcare system for Asia. Healthcare providers need to make significant investments in processes and technologies for cost reduction and increase patient outcome to succeed in the increasingly competitive environment. While healthcare sector is undergoing a system restructure and transformation process, the recent 1.5 million healthcare data breach in Singapore has highlighted our weakness in digital health transformation. Cyber security is a critical “cancer cell” that healthcare professionals need to focus before we benefited from the healthcare technologies.
The Asia healthcare challenges present tremendous opportunities to develop a world-class efficient and sustainable healthcare system. How to capitalize on the innovation trend to create new opportunities?
Questex Asia’s Healthcare Innovation Summit Asia will bring together 250+ senior stakeholders from regulators, policy makers, healthcare institutions, practitioners and technology innovators and solutions providers to discuss Asia healthcare innovation trends, collaboration strategies, investments opportunities in digital health and brainstorm partnership ideas to achieve quality healthcare and healthcare sustainability goals.
Networking & Learning
Health System Transformation Requires Rethinking of Data Infrastructure: Building a Viable and Sustainable Regional Data Defense System
Telemedicine is set to become a key feature of Singapore’s healthcare landscape and the Ministry is focusing on regulating Medical Practitioner-led tele-consultation and mobile medicine (house call) services that will soon become an important feature to increase accessibility of healthcare delivery in Singapore. What are the partnership opportunities and requirement for project assessment under LEAP before the new act is introduced?
Discuss the global trend and latest healthcare Blockchain pilot projects that potentially solve Cybersecurity threat and predict the impact of healthcare Blockchain for the next 5 years.
Discover the transformation journey and innovation roadmap of the Primary Care Provider of the Year, Patient Care Initiative of the Year, and Facilities Improvement Initiative of the Year.
The journey of a non-profit organization that is dedicated to empowering children through creative and expressive 3D-printed prosthetics.
Association of Private Hospitals Malaysia
Changi General Hospital
Farrer Park Hospital
Frost & Sullivan
Healthcare Technology Innovation Centre
IHH Healthcare Berhad
Khoo Teck Puat Hospital
KK Women's & Children's Hospital
Kwong Wai Shiu Hospital
Malaysian Genomics Research Center, MGRC
SingHealth Duke-NUS Institute of Precision Medicine
* Top 7 reasons why you should Sponsor *
1. Interact with Key Buyers, influencers and decisions makers from across the Asia Pacific Region
2. Generate quality leads at you network directly with your targeted audience through this curated event
3. Increase your business opportunities with ease in the Asia Pacific Region
4. Achieve business growth through the multitude of opportunities made available to you
5. Amplify your brand positioning to create Top-of-Mind-awareness among senior industry executives
6. Enjoy a wide reach as your company brand and solutions are amplified at this strategic platform
7. Succeed in engaging your targeted audience through an array of customizable sponsorship packages
Dr Timothy Low is currently the Head of Medical Affairs Asia Pacific at Shire. He was awarded 2018 Rare Disease Champion Provider of the Year in Asia Pacific. Concurrently, he was also conferred the Icons of Healthcare – Leading Healthcare Management Professional of the year.
Prior to joining Shire, Dr Low served as CEO of Farrer Park Hospital, a private acute tertiary institution sited within Singapore’s first fully integrated healthcare and hospitality complex. It was awarded “Best New Hospital in Asia Pacific” and “Smart Hospital of the Year in Asia Pacific” in 2016/2017 respectively. He currently serves as a member of the hospital’s Board of Directors.
With 30 years tenure in both public and private practice, Dr Low brings to this role his operational and medical knowledge. He formerly held the positions of CEO of Gleneagles Hospital and as Medical Affairs senior executive across pharmaceutical and medical device industries at Covidien, Schering Plough, Covance and GlaxoWellcome, spanning more than 17 years.
He was also awarded the “50 Most Talented Healthcare Leaders of Asia” award as well as “Best CEO of the Year” in 2016 and 2017 respectively.
Ms Chin Wei Jia was appointed as an Executive Director of HMI in October 2014 and as Group Chief Executive Officer (“CEO”) of HMI in September 2015. As Group CEO, she leads the strategic and operational activities in the Group. She also holds the concurrent appointment of CEO of Regency Specialist Hospital since 2012.
Ms Chin first joined HMI in 2002 and contributed to the launch of HMI Institute of Health Sciences. She played a key role in the development of HMI into a SGX mainboard listed healthcare company. Ms Chin was a member of the core team that commissioned HMI’s new Regency Specialist Hospital in 2008 and established HMI’s Medisave-accredited referral centre to enable HMI hospitals to provide overseas hospitalisation and day surgeries under the Singapore Medisave scheme.
Ms Chin holds a Bachelor of Arts (summa cum laude) in Economics and International Relations from Boston University, United States of America. She also has a Masters of Arts in International Relations from Johns Hopkins University, United States of America.
Associate Professor Madhu Bhaskaran co-leads the Functional Materials and Microsystems Research Group at RMIT University. She has won several awards and fellowships for her research including competitive Australian Research Council Postdoctoral Fellowship (2010-2014) and Australian Research Council DECRA Fellowship (2016-2018). In 2017 she was recognised with the Eureka Prize for Outstanding Early Career Researcher and also named as Australia’s Most Innovative Engineers by Engineers Australia. In 2018, she has won the Batterham Medal and the APEC Aspire Prize. Her research interests include functional oxide thin films, wearable technologies and stretchable electronics.
Michael D Winther is Associate Director at the Genome Institute of Singapore (GIS) and Head of offi ce of strategic alliances and knowledge management as of December 2015. Responsible for all agreements with academic, medical and industry organizations, as well as intellectual property developed by GIS. He is also the senior project manager for the national pharmacogenomics project SAPhIRE: Surveillance and Pharmacogenomics of Adverse Drug Reactions (www.saphire.sg). The SAPhIRE programme is developing the knowledge base and tools needed to implement pharmacogenomics at the wider community level to impact safety and effi cacy of biological and small molecule therapeutics. He has over 25 years R&D experience in biologicals and drug discovery with pharmaceutical and biotechnology companies and academia.
Prof. Patrick Tan is a Professor at the Duke-NUS Medical School and Deputy Executive Director of the Biomedical Research Council (Agency for Science, Technology and Research). He directs PRISM, the SingHealth Duke-NUS Institute of Precision Medicine, and was Program Director of POLARIS, which established the first CAP-certified facilities for next-generation sequencing and the first clinically implemented NGS panel in South East Asia, which to date has been been applied to >1000 cancer patients. He received his B.A. (summa cum laude) from Harvard University and MD PhD degree from Stanford University, where he received the Charles Yanofsky prize for Most Outstanding Graduate Thesis in Physics, Biology or Chemistry. Other awards include the President’s Scholarship, Loke Cheng Kim scholarship, Young Scientist Award (A-STAR), Singapore Youth Award (twice), SingHealth Investigator Excellence Award, Chen New Investigator Award (Human Genome Organization), President’s Science Award, and the Japanese Cancer Association International Award. In 2018, he received the American Association for Cancer Research (AACR) Team Science Award as Team Leader, representing the first time a team from Asia has received the award. He is an elected member of the American Society for Clinical Investigation (ASCI), the Bioethics Advisory Committee (BAC), a Board Member of the International Gastric Cancer Association, and co-chair of the Singapore National Precision Medicine Program Steering Committee.
Dr Pawel Suwinski is a medical professional with extensive knowledge and experience in clinical genomics, bioinformatics, healthcare informatics and economics. He is currently working with Malaysian Genomics Resource Centre Berhad as a clinical geneticist and medical bioinformatician. Prior to MGRC, he was a Principal Consultant with the Frost & Sullivan Asia Pacific, leading Healthcare Practice Division that focused on monitoring and analysing healthcare and life sciences emerging trends, technologies and market behaviour. Previous professional engagements included:
Dirk de Korne is the Deputy Director, Medical Innovation & Care Transformation at KK Women’s & Children’s Hospital (KKH). He also holds a position as Adjunct Assistant Professor at Duke-NUS Medical School, Singapore, and Erasmus School of Health Policy and Management, Erasmus University Rotterdam, Netherlands.
In KKH, he is responsible for the hospitals’ overall innovation strategy and execution, including the alignment and facilitation of initiatives and projects pertaining to cross-departments, multi-disciplinary collaborations towards patient service integration with relevant stakeholders.
Over the last 15 years, Dirk has focused on diffusion of innovations, quality and safety improvement and organizational strategy. He has been involved in, e.g., tele-health, e-health, health technology, risk management, human factors & ergonomics, performance indicators & benchmarking, safety culture, patient experience, design thinking, efficiency improvement and internal and external auditing.
He holds a MSc in Health Policy & Management from Erasmus University Rotterdam and a PhD in Public Health from University of Amsterdam.
Dr Milind Sabnis is the Director of the Healthcare Practice at Frost & Sullivan, Asia Pacific and is based in Singapore.
Milind has over a decade of consulting experience engaging global clients in the US, the UK and Asia Pacific. He specializes in strategy consulting, M&As, and public-private partnerships. He has advised top pharmaceutical/biotech companies, hospital groups, and ministries on market entry strategies, product lifecycle management, and marketing strategies that have positively impacted these organizations. While with the World Health Organization, he developed and successfully implemented various strategies to stop Polio transmission in one of the 3 high risk regions in the world.
He has spoken at and chaired multiple industry conferences and has been quoted in multiple industry magazines and journals. He has also been interviewed by various media, including BBC’s Asian Business Report.
He holds a Masters in Business Administration from the University of Cambridge, United Kingdom, a Doctor of Medicine specialising in Preventive Medicine from the University of Mumbai and a Bachelor of Medicine and Bachelor of Surgery from the University of Mumbai.
Peter Hennessy, Director, Jeta Global, has forty years’ experience in the health and aged care industries. Throughout his long career, Peter has embraced the challenges presented by industry and social change.
Studying contemporary planning issues in Australia and overseas, Peter is well equipped to provide uncompromising industry service. Academically he has tertiary qualifications in health administration, demographic analysis, social research, accounting and management.
Complementing his Jeta activities Peter holds several local and international Directorships on Corporate Boards and Statutory authorities. In recognition of his contribution to the health and aged care industries, Peter received an Adjunct appointment in the Centre for Population and Environmental Health Griffith University, Brisbane Australia.
Tamsin, a Fellow of the Royal Society for Public Health and member of DesignSingapore Council’s expert ‘Innovation by Design’ panel, has 20+ years of international experience in delivering change & transformation programmes, integrating risk communications, change leadership, and social innovation practices.
A graduate of Imperial College of Science, Technology and Medicine she was the first jointly-funded post holder between the London Borough of Barnet Local Planning Authority and Barnet Health Authority, pioneering integrated care initiatives. Subsequently working for the British Government’s Department of Health, she managed the UK’s longest running public health campaign, the Heartbeat Award.
Tamsin currently heads the Smart Health Leadership Centre at the National University of Singapore’s Institute of Systems Science, where she teaches digital leadership and health service transformation programmes. Tamsin established the Centre to assist stakeholders across the broad health ecosystem to transform the future experience of health through data, technology and innovation.
Tamsin is a skilled risk communications professional and published author, with international experience in leading and delivering fully integrated strategic communications, innovation and transformation programmes with award winning results.
Prior to joining NUS, she spearheaded the strategic communications & partnering strategies for the 2012 Major UK Civil Engineering Project of the Year, the New Tyne Crossing, transformation public perceptions and the project’s reputation.
Dr T Thirumoorthy graduated in 1972 from the University of Malaya (UM) as the Best All Round Graduating Student. After spending more than two years of his professional life in UK, he decided to come to Singapore, and his first job was Registrar in Dermatology and Venereology at the then-Middle Road Hospital. He was appointed Consultant dermatologist and venereologist in 1985 before finally leaving the National Skin Centre for private practice in 1990. Dr Thiru has been a member of the Academy of Medicine since 1981, and has served in the Chapter of Physicians as a committee member from 1987 to 1989. He has been a Fellow of the Royal College of Physicians London since 1989 and College of Physicians and Surgeons of Glasgow since 1990. He has been a member of the Ministry of Health National Medical Ethics Committee (NMEC) since 2005, and an elected member of the Singapore Medical Council (SMC) from 2005 to 2008. He has been a member of the Ethics Committee since 1988, and served on the SMA Council from 1997 to 1999, during which he chaired the Ethics Policy and Review Committee. He was the Organizing Chairman of the SMA Annual Ethics Convention from 1997 to 2002, and played a pivotal role in establishing the SMA Centre for Medical Ethics and Professionalism (SMA-CMEP) in 2000. He served as the Director of the Centre from 2000 to 2003, and continues to serve as a Board Member till today. In 2004, he was conferred the SMA Merit Award, for his outstanding leadership and contributions in the area of medical ethics and professionalism.
Dr. Daniel Chia Hock Thye graduated from the University of Singapore with B. Eng. (Hons) and was awarded Commonwealth Scholarship to pursue post graduate studies in innovations, systems design and technologies in UK. He graduated with M. Sc. with Essery Memorial Prize; and Ph. D. in Engineering and published papers in International journals. After returning from U.K., he obtained Diploma in Business Administration (NUS) and Diploma in Investments with prize from the Institute of Banking & Finance.
Dr. Chia served at the Singapore Technologies, where he worked in management, production, system designs and innovations. He went on to serve in Sembawang Corporation Limited, where he served in Corporate Development and was the Group Chief Information Officer of Sembawang Corporation Limite and the General Manager of RDC Pte Ltd, overseeing IT and Operation; and set up and operated engineering companies including RDC Medical Waste Incineration Pte Ltd.
He did part time lecturing in the National University of Singapore and the University of Newcastle upon Tyne on Information Technology for Business Applications, Innovations & Technopreneurship. He was invited to participate in lecture in NTU M. Sc. Technopreneurship & Innovation Programme on Strategic Management for New Ventures and Technology Firms.
Dr. Chia is currently the Director, Transformation Office, Khoo Teck Puat Hospital and serves in the Audit Committee of the National Kidney Foundation. He is also serving as the Chairman of School Advisory Committee of Riverside Secondary School.
Dr. Chia filed 16 patents locally and internationally of which 6 are for healthcare. Dr. Chia won a Public Service Award PBM from the President of Singapore for Community Services.
Dr Ngiam Kee Yuan is the Group Chief Technology Officer of the National University Health System (NUHS) Singapore overseeing technology deployment in Western Healthcare Cluster of Singapore. The cluster incorporates one large academic medical center, 3 national centers of excellence, 2 acute hospitals, one community hospital, 6 polyclinics and 4 schools under the National University of Singapore. In this role, he assists the Chief Executive to implement new technologies throughout NUHS and serves as the Chief Advisor to the Center for Innovation in Healthcare in NUHS. Dr Ngiam is concurrently the Deputy Chief Medical Informatics Officer at the National University Hospital of Singapore with a special focus on artificial intelligence research and implementation in healthcare. He has certification training by the American Medical Informatics Association and has published in computing and medical journals on topics related to healthcare AI applications and technology.
Dr Ngiam is a Consultant Thyroid and Endocrine Surgeon at the Department of Surgery, National University Hospital, Singapore specializing in thyroid oncology and minimally invasive endoscopic and robotic thyroid surgery. Dr Ngiam obtained his undergraduate degree from the Royal Free and University College Medical School, London (now University College London). He entered Advanced Surgical Training in General Surgery and was awarded a fellowship from the Royal College of Surgeons of Edinburgh upon completion of his training. He is accredited a general surgery specialist by the Specialist Accreditation Board, Singapore and received the Higher Manpower Development Award to complete a fellowship in Metabolic Surgery in Taiwan. He received further training in robotic thyroid surgery at the Seoul National University Hospital, South Korea.
In his capacity as Assistant Professor, Department of Surgery, Yong Loo Lin School of Medicine, National University of Singapore, Dr Ngiam engages in research into endocrine and metabolic surgery as well as artificial intelligence applications in healthcare. He promotes interdisciplinary collaboration throughout the NUS campus, particularly between the schools of medicine, engineering and computer science for various healthcare applications. He was awarded the ExxonMobil-NUS Research Fellowship for Clinicians and numerous teaching awards for his work in research and education.
Dr Ngiam is also active in volunteerism and is the Mission Chief for a number of ground up surgical missions to regional countries such as Myanmar and Indonesia; under the auspices of the Surgical Outreach to Underserved Localities (SOUL) program with the NUH Department of Surgery.
Dr Ow Chee Chung is currently the CEO of Kwong Wai Shiu Hospital. The hospital has now completed the major redevelopment to transform it into a Community Healthcare Hub. The hospital has doubled both its inpatient and outpatient capacities. It is now moving towards building a Regional Community Healthcare System
A medical doctor by training, Dr Ow also has a Master in Business Administration (MBA, Surrey). He has held several leadership appointments in the public service, VWOs and the healthcare sector such as the restructured hospitals and health institutions. He has a personal interest in the development of community care services.
Dr Tan Eng Lee graduated with his PhD in biomedical science from National University of Singapore in 2008. Dr Tan’s research interests include development of diagnostics for infectious diseases as well as oncology. He is currently the centre director for Digital Healthcare Innovation Centre, where he lead and strategise the IoT health and wellness innovations for step down care. He is the also the adjunct senior research fellow under the Department of Paediatrics in National University of Singapore.
Dr Tan has been awarded multiple grants from various agencies such as MOH New Investigator Grant, National Medical Research Council (NMRC), National Research Foundation Translational grant and Toteboard. To date, Dr Tan has published numerous international journals since 2008 and has filed 6 patents, with 2 of them licensed for commercialisation. Dr Tan has won many awards, notably the Best Innovative Award for Public Service in 2004, Excellence in Teaching Award in 2009 and Excellence in R&D Award in 2012.
Lenovo (HKSE: 992) (ADR: LNVGY) is a US$43 billion global Fortune 500 company and a leader in providing innovative consumer, commercial, and enterprise technology. Our portfolio of high-quality, secure products and services covers PCs (including the legendary Think and multimode Yoga brands), workstations, servers, storage, smart TVs and a family of mobile products like smartphones (including the Motorola brand), tablets and apps. Visit us at http://www.lenovo.com/
Pure Storage (NYSE: PSTG) helps innovators build a better world with data. Pure's data solutions enable SaaS companies, cloud service providers, and enterprise and public sector customers to deliver real-time, secure data to power their mission-critical production, DevOps, and modern analytics environments in a multi-cloud environment. One of the fastest growing enterprise IT companies in history, Pure Storage enables customers to quickly adopt next-generation technologies, including artificial intelligence and machine learning, to help maximize the value of their data for competitive advantage. And with a Satmetrix-certified NPS customer satisfaction score in the top one percent of B2B companies, Pure's ever-expanding list of customers are among the happiest in the world.
Materialise incorporates 27 years of 3D printing experience and has pioneered many of the leading medical applications of 3D printing, enables researchers, engineers and clinicians to revolutionize innovative patient-specific treatment that helps improve and save lives.
Materialise’s open and flexible platform of software and services, forms the foundation of certified Medical 3D Printing, in clinical as well as research environments, offering virtual planning software tools, 3D-printed anatomical models, and patient-specific surgical guides and implants.
For more information, visit http://www.materialise.com/medical.
Konica Minolta Business Solutions Asia is transforming the workplace of the future with its customer-centric solutions and hardware for the digitally connected world. We are committed to create new values for the society with our expertise. From information management to technology enabling tools, the solutions help businesses improve time to information, support mobility, and optimise business processes with workflow automation. Konica Minolta, Inc. has also been named to the Dow Jones Sustainability World Index for five years in a row. For more information, please visit http://www.konicaminolta.sg/business/
“The Asian Society for Quality in Health Care (ASQua) is a network of National Societies from the Asian region dedicated to the improvement of quality in healthcare at national and international levels. ASQua is committed to the achievement of its aims through collaborative action and in association with other health and quality related individuals and professional organisations in Asia. It was founded by a group of National Societies for quality in healthcare from Malaysia, Japan, Thailand, India, Taiwan and the Philippines, under the auspices of ISQua. It is committed to the achievement of its aims through collaborative action within the network and in association with other health and quality related individuals and professional organisations in Asia. Visit ASQua at www.asqua.org for more information.”
BNHC (founded in 2010) is a ‘purpose-driven’ consulting firm enabling commercial growth & outreach by bridging gaps though training, soft skills & technical expertise, market strategy & advisory services, specifically addressing the HealthTech domains within (but not limited to) Asia Pacific and Middle East region.
BinaryHealthCare (founded in 2002) is the social enterprise arm of BNHC, serving to “Bridge the eHealth Divide” (in low-resource settings) by enabling sustainable innovation in patient-centered care through stakeholders empowerment to achieve context-effective adoption of HealthTech as an enabler.
BinaryHealthCare serves to “Bridge the eHealth Divide” (in both LAMIC and Developed Countries) by enabling sustainable innovation in patient-centered care through stakeholders empowerment to achieve context-effective adoption of Digital Health as an enabler.
BinaryHealthCare is the social enterprise arm of BNHC, a ‘purpose-driven’ consulting firm offering training, technical and market strategy, solutions and advisory services, specifically addressing the eHealth domains within (but not limited to) the ASEAN, North Asia and Middle East region.
The Personal Connected Health Alliance (PCHAlliance) aims to make health and wellness an effortless part of daily life. The PCHAlliance, a non-profit organization formed by HIMSS, believes that health is personal and extends beyond healthcare. The PCHAlliance mobilizes a coalition of stakeholders to realize the full potential of personal connected health. PCHAlliance members are a vibrant ecosystem of technology and life sciences industry icons and innovative, early stage companies along with governments, academic institutions, and associations from around the world.
To support its vision, the PCHAlliance convenes the global personal connected health community at the annual Connected Health Conference, the premier international event for the exchange of research, evidence, ideas, innovations and opportunities in personal connected health.
The PCHAlliance publishes and promotes the global adoption of the Continua Design Guidelines, an open framework for user-friendly, interoperable health data exchange in personal connected health. The Continua Design Guidelines are recognized by the International Telecommunication Union (ITU), an agency of the United Nations, as the international standard for safe, secure, and reliable exchange of data to and from personal health devices.
The PCHAlliance accelerates technical, business, policy and social strategies necessary to advance personal connected health through its flagship key initiatives, including the Academy for Healthy Longevity, to promote lifelong health and wellness.
For more information, please contact: Francis Puno, Chairman – Southeast Asia at email@example.com
Healthcare Innovation focuses on how government, the pharmaceutical industry, and the healthcare service sector must work together to deliver innovative products and services for Asia’s rapidly changing economies and demographics. As one of the targeted verticals under Enterprise Innovation, the channel features specialized news and research on the healthcare industry, and a newsletter that is delivered to thousands of healthcare professionals across Asia.